Nigel P.S. Crawford

2.3k total citations
50 papers, 1.7k citations indexed

About

Nigel P.S. Crawford is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Nigel P.S. Crawford has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Genetics and 9 papers in Oncology. Recurrent topics in Nigel P.S. Crawford's work include Inflammatory Bowel Disease (8 papers), Prostate Cancer Treatment and Research (7 papers) and RNA Research and Splicing (6 papers). Nigel P.S. Crawford is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Prostate Cancer Treatment and Research (7 papers) and RNA Research and Splicing (6 papers). Nigel P.S. Crawford collaborates with scholars based in United States, United Kingdom and France. Nigel P.S. Crawford's co-authors include Kent W. Hunter, Jude Alsarraj, Luanne Lukes, Renard C. Walker, Susan Galandiuk, Gordon A. Melson, Keiko Ozato, Robert E. Petras, Argyrios Ziogas and Hoda Anton‐Culver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Nigel P.S. Crawford

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel P.S. Crawford United States 23 1.1k 471 399 237 167 50 1.7k
Carolyn Sidor United States 20 871 0.8× 433 0.9× 553 1.4× 280 1.2× 147 0.9× 42 1.6k
Wenyue Sun United States 24 1.2k 1.1× 600 1.3× 406 1.0× 110 0.5× 305 1.8× 65 1.8k
Yingli Sun China 17 2.2k 2.0× 417 0.9× 709 1.8× 153 0.6× 106 0.6× 26 2.6k
Donita Sanders United States 22 1.0k 1.0× 533 1.1× 403 1.0× 143 0.6× 203 1.2× 30 2.1k
Motoyoshi Tanaka Japan 22 919 0.9× 258 0.5× 361 0.9× 118 0.5× 244 1.5× 49 1.5k
Catherine M. Shachaf United States 13 784 0.7× 279 0.6× 381 1.0× 126 0.5× 61 0.4× 22 1.2k
Guanjun Wang China 24 835 0.8× 367 0.8× 310 0.8× 121 0.5× 148 0.9× 51 1.6k
Amen Sibtain United Kingdom 11 1.0k 0.9× 730 1.5× 333 0.8× 219 0.9× 233 1.4× 21 1.7k
Justin Gaudet United States 10 855 0.8× 344 0.7× 312 0.8× 167 0.7× 56 0.3× 10 1.4k
Fernando Doñate United States 22 897 0.8× 341 0.7× 508 1.3× 92 0.4× 145 0.9× 56 1.8k

Countries citing papers authored by Nigel P.S. Crawford

Since Specialization
Citations

This map shows the geographic impact of Nigel P.S. Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel P.S. Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel P.S. Crawford more than expected).

Fields of papers citing papers by Nigel P.S. Crawford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel P.S. Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel P.S. Crawford. The network helps show where Nigel P.S. Crawford may publish in the future.

Co-authorship network of co-authors of Nigel P.S. Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel P.S. Crawford. A scholar is included among the top collaborators of Nigel P.S. Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel P.S. Crawford. Nigel P.S. Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yanyan, Jyoti Sharma, Nigel P.S. Crawford, et al.. (2025). Drug–drug interaction study with itraconazole supplemented with physiologically based pharmacokinetic modelling to characterize the effect of CYP3A inhibitors on venglustat pharmacokinetics. British Journal of Clinical Pharmacology. 91(8). 2304–2315.
2.
Peterschmitt, Michel, et al.. (2020). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers. Clinical Pharmacology in Drug Development. 10(1). 86–98. 69 indexed citations
3.
Wong, Nora, Nigel P.S. Crawford, Jane Oliver, et al.. (2019). A cluster of paediatric invasive group A streptococcus disease in Melbourne, Australia coinciding with a high burden inluenza season.. Journal of the Pediatric Infectious Diseases Society. 2 indexed citations
4.
Winter, Jean M., Derek Gildea, Jonathan Andreas, et al.. (2016). Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer. Cell Systems. 4(1). 31–45.e6. 38 indexed citations
5.
Lewis, Monica, et al.. (2016). SIN3A and SIN3B differentially regulate breast cancer metastasis. Oncotarget. 7(48). 78713–78725. 31 indexed citations
6.
Williams, Kendra A., Ying Hu, Jonathan Andreas, et al.. (2015). GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes. Clinical & Experimental Metastasis. 32(8). 769–782. 43 indexed citations
7.
Williams, Kendra A., Ying Hu, Jonathan Andreas, et al.. (2014). A Systems Genetics Approach Identifies CXCL14, ITGAX, and LPCAT2 as Novel Aggressive Prostate Cancer Susceptibility Genes. PLoS Genetics. 10(11). e1004809–e1004809. 61 indexed citations
8.
Patel, Shashank J., Alfredo Molinolo, J. Silvio Gutkind, & Nigel P.S. Crawford. (2013). Germline Genetic Variation Modulates Tumor Progression and Metastasis in a Mouse Model of Neuroendocrine Prostate Carcinoma. PLoS ONE. 8(4). e61848–e61848. 22 indexed citations
9.
Dworkin, Amy M., et al.. (2013). RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1. Oncogene. 33(14). 1818–1827. 18 indexed citations
10.
Kanaan, Ziad, N. Shesh, M. Robert Eichenberger, et al.. (2012). Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Human Mutation. 33(3). 551–560. 108 indexed citations
11.
Alsarraj, Jude, Renard C. Walker, Joshua D. Webster, et al.. (2011). Deletion of the Proline-Rich Region of the Murine Metastasis Susceptibility Gene Brd4 Promotes Epithelial-to-Mesenchymal Transition- and Stem Cell-Like Conversion. Cancer Research. 71(8). 3121–3131. 56 indexed citations
12.
Lukes, Luanne, Nigel P.S. Crawford, Renard C. Walker, & Kent W. Hunter. (2008). The Origins of Breast Cancer Prognostic Gene Expression Profiles. Cancer Research. 69(1). 310–318. 29 indexed citations
13.
Hunter, Kent W., Nigel P.S. Crawford, & Jude Alsarraj. (2008). Mechanisms of metastasis. Breast Cancer Research. 10(S1). S2–S2. 221 indexed citations
14.
Crawford, Nigel P.S., et al.. (2008). The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival. Clinical & Experimental Metastasis. 25(4). 357–369. 54 indexed citations
15.
Crawford, Nigel P.S., Xiaolan Qian, Argyrios Ziogas, et al.. (2007). Rrp1b, a New Candidate Susceptibility Gene for Breast Cancer Progression and Metastasis. PLoS Genetics. 3(11). e214–e214. 68 indexed citations
16.
Crawford, Nigel P.S., et al.. (2007). CARD15 Genotype-Phenotype Relationships in a Small Inflammatory Bowel Disease Population with Severe Disease Affection Status. Digestive Diseases and Sciences. 52(10). 2716–2724. 10 indexed citations
17.
Crawford, Nigel P.S., M. Robert Eichenberger, Robert K. Lewis, et al.. (2005). Evaluation of SLC11A1as an inflammatory bowel disease candidate gene. BMC Medical Genetics. 6(1). 10–10. 9 indexed citations
18.
Yang, Haiyan, et al.. (2005). Metastasis Predictive Signature Profiles Pre-exist in Normal Tissues. Clinical & Experimental Metastasis. 22(7). 593–603. 91 indexed citations
19.
Crawford, Nigel P.S., et al.. (2003). Tumor markers and colorectal cancer: Utility in management. Journal of Surgical Oncology. 84(4). 239–248. 49 indexed citations
20.
Crawford, Nigel P.S. & Gordon A. Melson. (1968). Scandium(III) thiocyanate complexes with o-phenanthroline and 2-2′dipyridyl. Inorganic and Nuclear Chemistry Letters. 4(7). 399–401. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolyn Sidor Breakdown of academic impact, for papers by Wenyue Sun Breakdown of academic impact, for papers by Yingli Sun Breakdown of academic impact, for papers by Donita Sanders Breakdown of academic impact, for papers by Motoyoshi Tanaka Breakdown of academic impact, for papers by Catherine M. Shachaf Breakdown of academic impact, for papers by Guanjun Wang Breakdown of academic impact, for papers by Amen Sibtain Breakdown of academic impact, for papers by Justin Gaudet Breakdown of academic impact, for papers by Fernando Doñate
Rankless by CCL
2026